Drugs / LV
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT06225622 Background | Mar 2024 → Jan 2026 | colorectal cancer | Shanghai Zhongshan Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06225622 ↗ |
| Route | Intravenous | “400mg/m2, intravenous infusion” NCT06225622 ↗ |